Lysis of prostate carcinoma cells by trifunctional bispecific antibodies (αEpCAM × αCD3)

Journal of Histochemistry and Cytochemistry

Volumn 49, Issue 7, 2001, Pages 911-917

  Riesenberg, R ^a   Buchner, A ^a   Pohla, H ^a   Lindhofer, H ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Bispecific antibody; Computerized sequential; Double immunocytochemistry; Microscopy; Prostate carcinoma

Indexed keywords

CD3 ANTIGEN; IMMUNOGLOBULIN FC FRAGMENT; MONOCLONAL ANTIBODY; PERFORIN; TUMOR ANTIGEN;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER IMMUNOTHERAPY; CELL INTERACTION; CELL KILLING; CELL PROLIFERATION; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MALE; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; PROSTATE CARCINOMA;

EID: 0034978614     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1177/002215540104900711     Document Type: Article

References (21)

1. Cytosolic delivery of granzyme B by bacterial toxins: Evidence that endosomal disruption, in addition to transmembrane pore formation, is an important function of perforin
2. Immunosensitization of prostate carcinoma cell lines for lymphocytes (CTL, TIL, LAK)-mediated apoptosis via the Fas-Fas-ligand pathway of cytotoxicity
3. The cell biology of CTL killing
4. Increased potency of Fc-receptor-targeted antigens
5. Unprimed CD4+ and CDS+ T cells can be rapidly activated by a CD3 × CD19 bispecific antibody to proliferate and become cytotoxic
6. Construction and biological activity of a recombinant bispecific single-chain antibody designed for therapy of minimal residual colorectal cancer
7. Bispecific antibodies target operationally tumor-specific antigens in two leukemia relapse models
8. Bispecific antibodies effectively purge cancer cells from peripheral blood stem cell collections without effecting colony forming units
9. Preferential species-restricted heavy/light chain pairing in rat/mouse quadromas
10. Perforin: Structure and function
11. Ficoll-Isopaque gradients for the determination of density distributions of human blood lymphocytes and other reticulo-endothelial cells
12. Heterogeneous apoptotic responses of prostate cancer cell lines identify an association between sensitivity to staurosporine-induced apoptosis, expression of Bcl-2 family members, and caspase activation
13. Effects of the polyamine analogues N1-ethyl-N11-((cyclopropyl)methyl)-4,8-diazaundecane and N1-ethylN-11-((cycloheptyl)methyl)-4,8-diazaundecane in human prostate cancer cells
14. Cytotoxic lymphocyte granzymes trigger a target cell internal disintegration pathway leading to cytolysis and DNA breakdown
15. Phenylbutyrate-induced apoptosis and differential expression of Bcl-2, Bax, p53 and Fas in human prostate cancer cell lines
16. Immunocytochemical double staining of cytokeratin and prostate specific antigen in individual prostatic tumor cells
17. Randomized trial of monoclonal antibody for adjuvant therapy of resected colorectal carcinoma
18. Acquisition of immunologic self-tolerance
19. Aberrant sphingolipid signaling is involved in the resistance of prostate cancer cell lines to chemotherapy
20. The Fc-region of a new class of intact bispecific antibody mediates activation of accessory cells and NK cells and induces direct phagocytosis of tumour cells
21. Simultaneous activation of T cells and accessory cells by a new class of intact bispecific antibody results in efficient tumor cell killing